Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

On this page

  1. The Clinical Study Report (ICH E3)
  2. The Clinical Overview (ICH M4E)
  3. Relationship between the documents in a submission

Academy · Concepts & Definitions · Regulatory document sequence

From Clinical Study Report to Clinical Overview: The Relationship Between ICH Regulatory Documents

The Clinical Study Report and the Clinical Overview are not two versions of the same document. The former is the complete record of a single trial, whereas the latter is a cross-trial argument based on several such reports.

Pubrica AcademyWritten by a regulatory medical writer Reviewed bya clinical operations specialist Published10 October 2026 Last checked10 October 2026 Reading time8 minutes Sources2 peer-reviewed

In an ICH-format regulatory submission, the Clinical Study Report (CSR), structured according to ICH E3, documents a single clinical trial in full. The Clinical Overview, structured according to ICH M4E, is a higher-level document that synthesises the clinical evidence across all relevant studies in support of a specific regulatory submission.

Learning objectives

  • The sequential relationship between ICH E3 (the CSR) and ICH M4E (the Clinical Overview).
  • The level of detail appropriate to each document.
  • How the statistical analysis plan relates to the statistical methods, results and deviations presented in the clinical study report.

Common misconceptions

  • “The Clinical Overview is simply a shorter version of a CSR.” The Clinical Overview is a cross-study synthesis covering the overall benefit-risk assessment across potentially many trials, whereas a CSR documents one trial in the full depth specified by ICH E3; the two operate at different levels rather than being different lengths of the same content.
  • “The statistical analysis plan and the clinical study report present the same statistical content.” The statistical analysis plan details the planned analyses. The clinical study report presents the statistical methods, results and relevant deviations from the planned analyses.

The Clinical Study Report (ICH E3)

ICH E3 specifies the structure and content of a report for a single clinical trial, covering the study's design and methodology, the ethics and conduct of the trial, participant disposition, efficacy and safety results, and detailed statistical methods, with an extensive set of required appendices. It is the primary, complete record of what happened in that trial1.

The Clinical Overview (ICH M4E)

ICH M4E specifies the Clinical Overview, part of the Common Technical Document (CTD), which presents a critical analysis of the clinical data across all relevant studies supporting a marketing application — biopharmaceutics, clinical pharmacology, efficacy, and safety — culminating in an overall benefit-risk conclusion. It draws on, and references, the individual CSRs rather than repeating their full content2.

Relationship between the documents in a submission

In practice, the sequence is as follows: each trial supporting the submission produces its own CSR under ICH E3; once the relevant trials are complete and reported, the Clinical Overview under ICH M4E is written as a synthesising document that references and interprets those CSRs (along with other clinical summary documents in the CTD) to build the overall benefit-risk case presented to the regulator. The Clinical Overview cannot be written meaningfully before the underlying CSRs it depends on are substantially complete.

Key points

Key points

A CSR (ICH E3) documents one trial exhaustively, whereas a Clinical Overview (ICH M4E) is written subsequently, drawing on multiple CSRs, to present the cross-trial benefit-risk case for a submission. The statistical analysis plan details the planned analyses; the clinical study report presents the statistical methods, results and relevant deviations from the planned analyses.

Practical application

Practical application

  1. Drafting of the Clinical Overview should not begin until the relevant CSRs are substantially final. The Overview depends on and refers to specific CSR content, so drafting it against an unfinished CSR may necessitate rework.
  2. CSR-level statistical detail should be excluded from the Clinical Overview. The Overview should synthesise and interpret the evidence, referring to the CSR for the full statistical methodology rather than repeating it.
  3. The sponsor’s template should be checked to establish where SAP content is located. It should be confirmed whether the organisation treats the statistical analysis plan as a CSR appendix, a separate document referenced by the CSR, or another convention.

Frequently asked questions

No — ICH M4E specifies both; the Clinical Summary is a detailed, more comprehensive factual summary, while the Clinical Overview is a shorter, more interpretive, critical-analysis document.

No — a single Clinical Overview typically covers the full submission, drawing on all the relevant CSRs together, not one Overview per CSR.

Both are published by the International Council for Harmonisation (ICH) and available on the ICH website as current step-5 guidelines.

References

  1. ICH Harmonised Guideline. Structure and Content of Clinical Study Reports E3. read 10 October 2026. View ICH E3 guideline
  2. ICH Harmonised Guideline. Common Technical Document for the Registration of Pharmaceuticals for Human Use — Clinical Overview and Clinical Summary M4E(R2). read 10 October 2026. View ICH M4E guideline

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 10). From Clinical Study Report to Clinical Overview: The Relationship Between ICH Regulatory Documents. Pubrica. https://pubrica.com/academy/flowcharts/regulatory-document-sequence-flow/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Document-sequence reference

This reference is intended for use when planning submission document timelines.

1. Trial conducted and data locked
2. CSR drafted per ICH E3 structure (full study detail, all appendices)
3. CSR finalised
4. Clinical Overview drafted per ICH M4E, referencing finalised CSR(s)
5. Clinical Overview integrated into the CTD alongside the Clinical Summary and other modules

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica prepares Clinical Study Reports structured according to ICH E3 and Clinical Overviews structured according to ICH M4E, and sequences the two appropriately within the overall timeline of a submission.

Submit an enquiry Get help with your regulatory document sequence

Explore

Related Academy articles

Selected from the same topic and category, with the most recent first.

Article

What is a literature review in research methodology?

The types, the steps, the structure, and the difference between a literature review and a systematic review that reviewers keep having to point out.

2 October 2026 · 7 min read

Article

What is the purpose and importance of literature reviews in research?

The four things a review establishes that no other section can, and what separates one that works from one that summarises.

2 October 2026 · 5 min read

Article

How to write a research proposal: a complete guide

The standard sections, the methodology detail reviewers look for, and the sample size objection that sinks most of them.

2 October 2026 · 7 min read

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Mapping the CSR-to-Overview sequence for a Common Technical Document (CTD) submission

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote Ask about your own case
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.